Frequency Therapeutics Financials
FREQDelisted Stock | USD 0.52 0.03 5.45% |
Frequency |
Understanding current and past Frequency Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Frequency Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Frequency Therapeutics' assets may result in an increase in income on the income statement.
Frequency Therapeutics Stock Summary
Frequency Therapeutics competes with Lineage Cell, MAIA Biotechnology, Armata Pharmaceuticals, Portage Biotech, and Pmv Pharmaceuticals. Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a persons innate regenerative potential to restore function. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Frequency Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.Foreign Associate | Canada |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US35803L1089 |
Business Address | 75 Hayden Avenue, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.frequencytx.com |
Phone | 781 315 4600 |
Currency | USD - US Dollar |
Frequency Therapeutics Key Financial Ratios
Frequency Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Frequency Therapeutics's current stock value. Our valuation model uses many indicators to compare Frequency Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Frequency Therapeutics competition to find correlations between indicators driving Frequency Therapeutics's intrinsic value. More Info.Frequency Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Frequency Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Frequency Therapeutics Market Pulse
Quote | 0.52 |
Change(%) | 5.45 |
Change | 0.03 |
Open | 0.55 |
Low | 0.45 |
High | 0.6 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Frequency Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Frequency has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Frequency Therapeutics' financials are consistent with your investment objective using the following steps:- Review Frequency Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Frequency Therapeutics' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Frequency Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Frequency Therapeutics' stock is overvalued or undervalued.
Frequency Therapeutics November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Frequency Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Frequency Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Frequency Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Frequency Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Frequency Therapeutics's daily price indicators and compare them against related drivers.
Downside Deviation | 5.52 | |||
Information Ratio | 0.056 | |||
Maximum Drawdown | 90.18 | |||
Value At Risk | (6.15) | |||
Potential Upside | 5.71 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Frequency Stock
If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |